Draft Documents to Support Submission of an Electronic Common Technical Document; Availability
Document ID: FDA-2011-N-0724-0001
Comments
Total: 8
-
GlaxoSmithKline - Comment
Posted : 12/22/2011 ID :FDA-2011-N-0724-0002 Agency : FDA -
Dec 27,2011 11:59 PM ET
-
Sanofi - Comment
Posted : 12/22/2011 ID :FDA-2011-N-0724-0003 Agency : FDA -
Dec 27,2011 11:59 PM ET
-
MacroGenics, Inc. - Comment
Posted : 01/05/2012 ID :FDA-2011-N-0724-0004 Agency : FDA -
Dec 27,2011 11:59 PM ET
-
Boehringer Ingelheim Pharmaceuticals, Inc. - Comment
Posted : 01/05/2012 ID :FDA-2011-N-0724-0005 Agency : FDA -
Dec 27,2011 11:59 PM ET
-
Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Posted : 01/05/2012 ID :FDA-2011-N-0724-0006 Agency : FDA -
Dec 27,2011 11:59 PM ET
-
IRISS - Comment
Posted : 01/05/2012 ID :FDA-2011-N-0724-0007 Agency : FDA -
Dec 27,2011 11:59 PM ET
-
Biologics Consulting Group - Comment
Posted : 01/05/2012 ID :FDA-2011-N-0724-0008 Agency : FDA -
Dec 27,2011 11:59 PM ET
-
Liquent - Comment
Posted : 01/05/2012 ID :FDA-2011-N-0724-0009 Agency : FDA -
Dec 27,2011 11:59 PM ET